HARDING THOMAS C. (See Remarks) sold 0.2% of their position (7.00 shares) of CLOVIS ONCOLOGY, INC. on the open market
Open‑market sale worth $18.97 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/6/2022ACC: 0000899243-22-025333
Officer· See Remarks
Since Dec 2020
-7.00
Net shares
Net seller
$18.97
Total sold
1
Open market trades
0B · 1S
3
Total transactions
16.00 acquired · 23.00 disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+16.00
Price / share
—
Trade value
—
% of position
0.5%
7/1/2022
3.23K→3.24K
Common Stock
Indirect
Shares
−7.00
Price / share
$2.71
Trade value
$18.97
% of position
0.2%
7/5/2022
3.24K→3.23K
Total
Net shares
+9.00
Net value
-$18.97
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 7/1/2022 | M · Option Exercise | +16.00 | — | — | 0.5% | 3.23K | 3.24K |
| Common Stock Indirect | 7/5/2022 | S · Sale | −7.00 | $2.71 | $18.97 | 0.2% | 3.24K | 3.23K |
| Total | +9.00 | -$18.97 | ||||||
Derivative Transactions1
Restricted Stock Units
Indirect
Converts to
Common Stock
16.00 shares
Shares
−16.00
Strike price
Held after
124.00
Exercisable
—
7/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Indirect | Common Stock16.00 shares | 7/1/2022 | M · Option Exercise | −16.00 | — | 124.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned14.72K
Total
14.72K direct14.72K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 14.72K | Direct |
| Total | 14.72K | 14.72K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported